Literature DB >> 35676116

Reply.

Ana Piñar-Gutiérrez1, Pablo Remón-Ruiz2, Alfonso Soto-Moreno2.   

Abstract

Entities:  

Year:  2022        PMID: 35676116      PMCID: PMC9552192          DOI: 10.1016/j.medcli.2022.02.026

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   3.200


× No keyword cloud information.
Dear Editor, We would like to share ideas on the publication “Pituitary apoplexy and COVID-19 vaccination: correspondence”. Our manuscript emphasizes that, unfortunately, the vaccination could not be demonstrated as the cause of the apoplexy with certainty. However, following the WHO Assessment of causality of individual adverse events following immunization (AEFI) tool, we believe that this case meets the most relevant criteria: temporality and known causal association (VITT). The patient had no other classic risk factors for pituitary apoplexy: pregnancy, postpartum, trauma, hypertension, coagulopathy, recent surgery, or age in the 5–6th decade of life. She also did not present any concurrent incidences. Besides, our patient did not meet the epidemiological criteria for dengue nor did she present suspicious symptoms according to the Andalusian Dengue Surveillance Plan.

Funding resources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors declare no conflict of interests.
  3 in total

1.  Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.

Authors:  Alberto E Tozzi; Edwin J Asturias; Madhava Ram Balakrishnan; Neal A Halsey; Barbara Law; Patrick L F Zuber
Journal:  Vaccine       Date:  2013-09-08       Impact factor: 3.641

2.  Pituitary apoplexy after COVID-19 vaccination: Correspondence.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Med Clin (Barc)       Date:  2022-07-20       Impact factor: 3.200

3.  Characterization of the first autochthonous dengue outbreak in Spain (August-September 2018).

Authors:  Susana Monge; Visitación García-Ortúzar; Begoña López Hernández; María Ángeles Lopaz Pérez; Sarah Delacour-Estrella; María Paz Sánchez-Seco; Beatriz Fernández Martinez; Lucía García San Miguel; Ana García-Fulgueiras; María José Sierra Moros
Journal:  Acta Trop       Date:  2020-02-20       Impact factor: 3.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.